This clinical trial studies whether an electronic health (eHealth)-based psychosocial and physical symptom management intervention (ePSMI) improves quality of life in patients with pancreatic cancer (PaCa). Treatment of PaCa can be complicated and may include both chemotherapy and surgery. This complicated treatment approach can lead patients to experience changes to their gastrointestinal function, emotional well-being, and other multiple areas of health-related quality of life. The ePSMI is a web-based program that uses common cognitive behavior therapy-based skills to help patients change their behavior by changing the way they think and feel about certain things. The ePSMI focuses on managing PaCa and stress and self-management skills. This may help patients to cope with the changes that happen from PaCa treatment, which may help to improve their quality of life.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06893276.
Locations matching your search criteria
United States
Florida
Coral Gables
UM Sylvester Comprehensive Cancer Center at Coral GablesStatus: Active
Contact: Frank J. Penedo
Miami
University of Miami Miller School of Medicine-Sylvester Cancer CenterStatus: Active
Contact: Frank J. Penedo
Phone: 305-284-4290
UM Sylvester Comprehensive Cancer Center at KendallStatus: Active
Contact: Frank J. Penedo
Plantation
UM Sylvester Comprehensive Cancer Center at PlantationStatus: Active
Contact: Frank J. Penedo
PRIMARY OBJECTIVES:
I. Adapt/refine an ePSMI program for PaCa patients.
II. Assess the feasibility and acceptability of the ePSMI program.
OUTLINE:
AIM 1: Participants are assigned to 1 of 2 groups.
GROUP I: Patients complete a semi-structured interview over 2 hours and complete questionnaires on study.
GROUP II: Providers complete a semi-structured interview over 30 minutes and complete a survey over 1 minute on study.
AIM 2: Patients complete ePSMI program sessions consisting of learning new anxiety/arousal techniques and stress-and self-management over 90 minutes once a week (QW) for 10 weeks.
After completion of study intervention, patients are followed up at 10 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Miami Miller School of Medicine-Sylvester Cancer Center
Principal InvestigatorFrank J. Penedo